Helius Medical Tech Q2 2024 GAAP EPS $(0.64) Misses $(0.50) Estimate, Sales $182.000K Beat $150.000K Estimate
Author: Benzinga Newsdesk | August 12, 2024 04:07pm
Helius Medical Tech (NASDAQ:
HSDT) reported quarterly losses of $(0.64) per share which missed the analyst consensus estimate of $(0.50) by 28 percent. The company reported quarterly sales of $182.000 thousand which beat the analyst consensus estimate of $150.000 thousand by 21.33 percent. This is a 28.91 percent decrease over sales of $256.000 thousand the same period last year.
Posted In: HSDT